ClinicalTrials.govpublic full text
Entecavir With or Without Pegylated Interferon α-2b in Children Aged 3-6 Years With Immune-Active Chronic Hepatitis B
hepatitis b virus infection, children, chronic hepatitis b, efficacy, immune clearance, safety, chronic, entecavir, pegylated interferon α-2b, functional cure, hepatitis b virus, interventional
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 900998
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.